Benjamin F. Edwards & Company, Inc. Haemonetics Corp Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.69 Billion
- Q2 2024
A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 60 shares of HAE stock, worth $4,546. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60
Previous 104
42.31%
Holding current value
$4,546
Previous $9,000
44.44%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HAE
# of Institutions
354Shares Held
53MCall Options Held
653KPut Options Held
553K-
Black Rock Inc. New York, NY5.96MShares$452 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$386 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.35MShares$329 Million0.24% of portfolio
-
Wellington Management Group LLP Boston, MA2.62MShares$199 Million0.03% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.2MShares$166 Million0.09% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.89B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...